(600518)"Kangmei Pharmaceutical Co., Ltd."Announcement on Share Repurchase Plan through Call Auction
Filed with SSE · Stock code 600518 · · 7 pages · Chinese
Summary by 6ix AI
Kangmei Pharmaceutical Co., Ltd has announced a share repurchase plan through a call auction. The plan involves repurchasing shares with a total amount between a minimum and maximum threshold. The repurchased shares will be used for employee stock ownership plans or equity incentives. The repurchase will occur within a specified timeframe and is subject to market conditions. The company has outlined potential risks associated with the implementation of this repurchase plan.
Written in English by 6ix AI from the company’s Chinese-language filing. How 6ix writes summaries
Kangmei Pharmaceutical Co., Ltd on 6ix
Story so far
Earlier from Kangmei Pharmaceutical
- Announcement on Resolutions of the 6th Extraordinary Meeting of the 10th Board of Directors in 2026
- Announcement on Convening the 2026 Semi-annual Performance Briefing
- Announcement on Progress of Litigation Involved (II)
- Notice on Convening the 2nd Extraordinary General Meeting in 2026
- Announcement on Progress in Litigation Involved
Later from Kangmei Pharmaceutical
- (600518)"Kangmei Pharmaceutical Co., Ltd."Announcement on Progress of Litigation Involved (III)
- (600518)"Kangmei Pharmaceutical Co., Ltd."Announcement on Progress in Repurchasing Shares
- (600518)"Kangmei Pharmaceutical Co., Ltd."Announcement on Shareholdings of Top 10 Shareholders and Top 10 Shareholders Holding Unrestricted Shares Concerning Share Repurchase
Follow Kangmei Pharmaceutical into a list and get an email when it puts out news.
Follow Kangmei Pharmaceutical